NP Life Sciences Health Industry Group Inc. (ACAT) Operating cash flow 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$73,607FY2023 · since FY2019: -$4,266 → -$73,607
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$73,607 | -178.4% |
| FY2022 | $93,873 | +203.6% |
| FY2021 | -$90,625 | +27.1% |
| FY2020 | -$124,322 | -2814.3% |
| FY2019 | -$4,266 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT RevenueACAT Net incomeACAT Net marginACAT Gross profitACAT Gross marginACAT Operating incomeACAT Operating marginACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Total liabilitiesACAT Shareholders’ equityACAT overview →